Concepedia

Inge A.T. Hermens

IA

Statistics

Publications

2

Citations

34

H-Index

2

Active since

2021

Affiliations

The Netherlands Cancer Institute(Current)

Inge A.T. Hermens is an author at The Netherlands Cancer Institute specializing in immunology, natural killer cell biology, and cancer immunotherapy.

ORCID

Publications per year

2021–2023

2

Publications

2

Clinically applicable CD34+-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses

Jesper van Eck van der Sluijs, Diede van Ens, Soley Thordardottir et al. · Cancer Immunology Immunotherapy · 2021 · 23 citations · Full text

, , +10

Preclinical Profile of BYON3521 Predicts an Effective and Safe MET Antibody–Drug Conjugate

Patrick G. Groothuis, Daniëlle C.H. Jacobs, Inge A.T. Hermens et al. · Molecular Cancer Therapeutics · 2023 · 11 citations · Full text

, , +17

1–2 of 2